Avid Radiopharmaceuticals, Inc. and Siemens PETNET Solutions Collaborate on Manufacturing of ß-amyloid Imaging Agent, Florbetapir F 18 (18F-AV-45)

PHILADELPHIA & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc. (“Avid”) and PETNET Solutions, Inc. (“PETNET”), a wholly-owned subsidiary of Siemens Medical Solutions, USA, Inc. (“Siemens”, NYSE: SI), marked the first dose shipped from a PETNET Solutions manufacturing facility as part of its collaboration with Avid on Florbetapir F 18 (18F-AV-45 or Florbetapir), Avid’s molecular imaging agent for positron emission tomography (PET) imaging of ß-amyloid deposits in the brain, a key pathological component of Alzheimer’s disease.